Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
8 pending office actions • 8 clients • 8 examiners • 8 art units • 0 of 8 (0%) have an AI response strategy ready
BAKER & MCKENZIE LLP (Dallas account) handles Biotechnology & Pharmaceuticals, with 8 pending office actions and 2625 career applications. The current docket is limited in relation to the firm’s recorded application activity, placing the active matters within a broad prosecution history.
The resolved allowance rate is 89.69%, and the average is 2.82 office actions per allowance. Resolved matters have commonly reached allowance after several examination exchanges. Practitioners should combine careful response planning with close attention to the biological, pharmaceutical, and therapeutic distinctions that define claim scope.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 1 (12%) |
| §102 only | 1 (12%) |
| Double-patenting only | 1 (12%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COHEN, MICHAEL P | 1 | 58.9% | +27.3% |
| ZEE, EDWARD | 1 | 90.6% | +10.3% |
| CHEN, VIVIAN | 1 | 56.6% | +28.5% |
| BAKER, LORI LYNN | 1 | 78.6% | +6.6% |
| BROWN, SETH RICHARD | 1 | 48.9% | +44.3% |
| POPOVICS, ROBERT J | 1 | 55.4% | +23.1% |
| MILLNER, MONICA E | 1 | 77.4% | +21.8% |
| GUSSOW, ANNE | 1 | 57.9% | +43.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19183340 | DOMAIN-SPECIFIC LANGUAGE SIMULANT FOR SIMULATING A THREAT-ACTOR AND ADVERSARIAL TACTICS, TECHNIQUES, AND PROCEDURES | ZEE, EDWARD | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19326649 | METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS | COHEN, MICHAEL P | — |
| 18990511 | Toilet Flange Nut | BAKER, LORI LYNN | — |
| 18958154 | CURVED LINKAGE SYSTEM FOR A SHOULDER BRACE | BROWN, SETH RICHARD | — |
| 18037003 | SYSTEMS FOR THE DETECTION OF TARGETED GENE VARIATIONS AND VIRAL GENOMES AND METHODS OF PRODUCING AND USING SAME | GUSSOW, ANNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19326649 | METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS | COHEN, MICHAEL P | — |
| 19183340 | DOMAIN-SPECIFIC LANGUAGE SIMULANT FOR SIMULATING A THREAT-ACTOR AND ADVERSARIAL TACTICS, TECHNIQUES, AND PROCEDURES | ZEE, EDWARD | — |
| 19042918 | Composite Thermoplastic Laminate | CHEN, VIVIAN | — |
| 18958154 | CURVED LINKAGE SYSTEM FOR A SHOULDER BRACE | BROWN, SETH RICHARD | — |
| 18791677 | METHODS AND SYSTEMS FOR DEWATERING SOLID PARTICLES IN A CONTAMINATED LIQUID MIXTURE | POPOVICS, ROBERT J | — |
| 18640587 | MOUNTING BAR CONNECTION SYSTEM | MILLNER, MONICA E | — |
| 18037003 | SYSTEMS FOR THE DETECTION OF TARGETED GENE VARIATIONS AND VIRAL GENOMES AND METHODS OF PRODUCING AND USING SAME | GUSSOW, ANNE | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Anti-Viral Technologies, LLC | 1 |
| QUALYS, INC. | 1 |
| Xamax Industries, Inc. | 1 |
| Coflex S.A. De C.V. | 1 |
| Breg, Inc. | 1 |
| 1934612 Ontario Inc. | 1 |
| Cinelease, LLC | 1 |
| World Biotech Regenerative Medical Group Limited | 1 |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 2435 | 1 |
| 1787 | 1 |
| 3754 | 1 |
| 3786 | 1 |
| 1776 | 1 |
| 3634 | 1 |
| 1683 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19326649 | METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS | Anti-Viral Technologies, LLC | COHEN, MICHAEL P | 1612 | §103§112 | Non-Final OA | — | Pending | Sep 11, 2025 |
| 19183340 | DOMAIN-SPECIFIC LANGUAGE SIMULANT FOR SIMULATING A THREAT-ACTOR AND ADVERSARIAL TACTICS, TECHNIQUES, AND PROCEDURES | Qualys, Inc. | ZEE, EDWARD | 2435 | DP | Non-Final OA | — | Pending | Apr 18, 2025 |
| 19042918 | Composite Thermoplastic Laminate | Xamax Industries, Inc. | CHEN, VIVIAN | 1787 | §112DP | Non-Final OA | — | Pending | Jan 31, 2025 |
| 18990511 | Toilet Flange Nut | Coflex S.A. De C.V. | BAKER, LORI LYNN | 3754 | §102§103 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18958154 | CURVED LINKAGE SYSTEM FOR A SHOULDER BRACE | Breg, Inc. | BROWN, SETH RICHARD | 3786 | §103§112 | Final Rejection | — | Pending | Nov 25, 2024 |
| 18791677 | METHODS AND SYSTEMS FOR DEWATERING SOLID PARTICLES IN A CONTAMINATED LIQUID MIXTURE | 1934612 Ontario Inc. | POPOVICS, ROBERT J | 1776 | §103Other | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18640587 | MOUNTING BAR CONNECTION SYSTEM | Cinelease, LLC | MILLNER, MONICA E | 3634 | §102 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18037003 | SYSTEMS FOR THE DETECTION OF TARGETED GENE VARIATIONS AND VIRAL GENOMES AND METHODS OF PRODUCING AND USING SAME | World Biotech Regenerative Medical Group Limited | GUSSOW, ANNE | 1683 | §101§103§112 | Non-Final OA | — | Pending | May 15, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial89.7% of resolved applications prosecuted by Baker & Mckenzie LLP (Dallas Account) were allowed, across 2,625 applications in USPTO records.
2.82 office actions per allowed application on average.
8 pending office actions as of October 2026, for 8 clients, before 8 examiners in 8 art units.
